NIFTY 50

Serum Institute and Bharat Biotech start dispatching COVID-19 vaccines; here's a ground report

Updated : January 12, 2021 06:01 PM IST

It has been a landmark day in India's fight against COVID-19, the virus which has claimed over 1.5 lakh lives across the country in less than a year. Four days ahead of the coronavirus vaccine rollout, dosage from both Serum Institute in Pune and Bharat Biotech in Hyderabad are being shipped to multiple destinations.

About 3 crore healthcare and frontline workers will be the first ones to receive these vaccine, beginning the 16th of January.

Serum Institute's Adar Poonawala has reiterated that the company will supply the first 100 million dosage of Covishield to the government for 200 per dose. However, he added that after that, the company intends to sell Covishield in the private market for Rs 1,000 per dose. He also expects people with no co-morbidities to receive the vaccine in two months.

The health ministry has confirmed that people will not have the option of choosing between Covaxin and Covishield. The government also said that the entire process of vaccination will last more than a year.

CNBC-TV18's team of reporters report on the prices, dosage and how the operation for delivery and storage of these vaccines.

Watch video for more.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more
Live TV

recommended for you